Viewing Study NCT07073833


Ignite Creation Date: 2025-12-25 @ 2:54 AM
Ignite Modification Date: 2025-12-31 @ 5:06 PM
Study NCT ID: NCT07073833
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2025-06-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma
Sponsor: Imbioray (Hangzhou) Biomedicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module